Pyxis Oncology (PYXS) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
Pyxis Oncology (PYXS) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | -0.40 |
| 10 | Pyxis Oncology | 206.05 Mn | 173.06 Mn | - | -0.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.40 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -0.35 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | -0.61 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.29 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | -0.41 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -0.43 |
| Mar 31, 2023 | -0.55 |
| Dec 31, 2022 | -1.09 |
| Sep 30, 2022 | -0.85 |
| Jun 30, 2022 | -0.79 |
| Mar 31, 2022 | -0.97 |
| Dec 31, 2021 | -1.93 |
| Sep 30, 2021 | -7.34 |
| Jun 30, 2021 | -4.03 |